Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer. (2018)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.24400
PubMed Identifier: 29560112
Publication URI: http://europepmc.org/abstract/MED/29560112
Type: Journal Article/Review
Volume: 9
Parent Publication: Oncotarget
Issue: 16
ISSN: 1949-2553